The Indian pLN Registry, which began in 2020, is the first prospective initiative of its kind in a low- and middle-income country (LMIC). It collects data from multiple centers across India to better understand the clinical characteristics, laboratory parameters, and renal biopsy findings in children (≤18 years) diagnosed with lupus and nephritis. The present report captures the initial clinical presentation of these children and highlights some stark patterns.
The following were the key findings of the study:
- Of the 154 children enrolled in the registry by July 2024, 75% were female. The median age at diagnosis was 12 years.
- Most children had kidney involvement at the time of lupus diagnosis, while others developed nephritis within five years.
- Edema was present in 75% of the children.
- Hypertension was in 54% of cases.
- Proteinuria was detected in 98% of children, with nearly 70% exhibiting nephrotic-range protein loss.
- Acute kidney injury (AKI) occurred in 43% of patients, with 20% having stage 3 AKI.
- Low complement levels (C3, C4, or both) were in 94% of the cohort.
- Anti-nuclear antibody positivity was seen in 96% of children.
- Class IV lupus nephritis was the most common renal biopsy finding, affecting 45% of patients.
- Class IV lupus nephritis was associated with significantly lower kidney function compared to Class V, indicating a more severe disease course.
The researchers noted that AKI, often overlooked in earlier studies due to retrospective data limitations, was found to be far more common when assessed prospectively. Given its independent link with increased morbidity and mortality, early identification and management of AKI in pediatric lupus is critical.
The report highlights the urgent need for better awareness, early diagnosis, and robust follow-up in managing pediatric lupus nephritis, particularly in resource-constrained settings. As children enrolled in the registry continue to be followed up, researchers hope to gain deeper insights into treatment responses and long-term outcomes, which could ultimately help refine care protocols and improve prognosis for affected children in LMICs.
The authors concluded, "The study emphasizes the value of prospective data collection in understanding disease burden more accurately and shaping more effective, evidence-based strategies for managing pediatric lupus nephritis."
Reference:
Poddar, S., Dasgupta, D., Pradhan, S. et al. Clinical presentation of children with lupus nephritis from a low- and middle-income country (LMIC): an initial report from the Indian pSLE Nephritis Registry. Clin Rheumatol (2025). https://doi.org/10.1007/s10067-025-07576-9
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.